Skip to Main Content

Paper Details

Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
Nature Communications
10
2021
atrial fibrillation, atrial human pluripotent stem cell-derived cardiomyocytes, human
Author NameAffiliation
Thomas EschenhagenCardiovascular Research Center, University Medical Center Hamburg-Eppendorf
Thomas Eschenhagen
  • 1 - 2

Datasets

Release 1.2